Can Huntington's disease clinical trial design tweaks lead t

After a series of disappointing clinical trial data in Huntington’s disease, study design changes take aim at moving the field forward.

Related Keywords

Canada , Neurocrine Biosciences , Prilenia Hayden , Annexon Biosciences , Prelinia Hayden , Christopher Ross , Lundbeck Xenazine , Michael Hayden , Wave Life Sciences , Prilenia Therapeutics , Annexon Bioscience , Unified Huntington , Disease Rating Scale , Total Functional Capacity , John Hopkins , Total Motor Score , Although Wave , Total Maximal Chorea , Teva Pharmaceutical , Regulatory Consultation , Preference Management Solution ,